{
    "SPADE_UN_27142": {
        "Sequence Information": {
            "Peptide Name": "T22, Polyphemusin II [Tyr-5,12, Lys-7]",
            "Sequence": "RRWCYRKCYKGYCYRKCR",
            "Sequence Length": 18,
            "Biological Activity": [
                "Antiviral"
            ],
            "Binding Target": "1. Lipid Bilayer\n2. Virus entry",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P14216",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P14216",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.",
                    "Pubmed ID": "1384424",
                    "Reference": "Antimicrob Agents Chemother. 1992;36:1249-1255",
                    "Author": "Nakashima H, Masuda M, Murakami T, Koyanagi Y, Matsumoto A, Fujii N, Yamamoto N",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/1384424"
                }
            ],
            "Mass": 2491.99,
            "PI": 9.96,
            "Net Charge": 8,
            "Hydrophobicity": -1.71,
            "Frequent Amino Acids": "RCY",
            "Absent Amino Acids": "ADEFHILMNOPQSTUV",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 14,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_27142",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_21507",
                    "Similarity": 1.0,
                    "Sequence": "WRRWRRRWRRRWRRW"
                },
                {
                    "SPADE_ID": "SPADE_UN_27142",
                    "Similarity": 1.0,
                    "Sequence": "RRWCYRKCYKGYCYRKCR"
                },
                {
                    "SPADE_ID": "SPADE_UN_12133",
                    "Similarity": 1.0,
                    "Sequence": "RKCRIVVIRVCR"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "HIV-1 HTLV-IIIB(EC50=0.008±0.003µg/ml),HIV-1 HTLV-IIIB(EC50=0.063±0.057µg/ml),HIV-1 A012B(EC50=0.006±0.0005µg/ml),HIV-1 A012D(EC50=0.006±0.0004µg/ml),HIV-1 A018A(EC50=0.014±0.0003µg/ml),HIV-1 A018C(EC50=0.024±0.0003µg/ml),HIV-2 ROD(EC50=0.031±0.018µg/ml),HIV-2 EHO(EC50=0.071±0.0003µg/ml),HIV-1 HTLV-IIIB(IC50 F=0.032-0.16µg/ml)"
        }
    }
}